Literature DB >> 18197187

Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset Alexander disease.

Tiziana Bachetti1, Francesco Caroli, Paola Bocca, Ignazia Prigione, Pietro Balbi, Roberta Biancheri, Mirella Filocamo, Caterina Mariotti, Davide Pareyson, Roberto Ravazzolo, Isabella Ceccherini.   

Abstract

Alexander disease is a neurological genetic disorder characterized by progressive white-matter degeneration, with astrocytes containing cytoplasmic aggregates, called Rosenthal fibers, including the intermediate filament glial fibrillary acidic protein (GFAP). The age of onset of the disease defines three different forms, infantile, juvenile and adult, all due to heterozygous GFAP mutations and characterized by a progressive less severe phenotype from infantile to adult forms. In an Italian family with a recurrent mild adult onset of Alexander disease, we have identified two GFAP mutations, coupled on a same allele, leading to p.[R330G; E332K]. Functional studies on this complex allele revealed less severe aggregation patterns compared to those observed with p.R239C GFAP mutant, associated with a severe Alexander disease phenotype. Moreover, in addition to confirming the involvement of the ubiquitin-proteasome system in cleaning cells from aggregates and a dominant effect of the novel mutant protein, in cells expressing the mild p.[R330G; E332K] mutant we have observed that indirect alphaB-crystallin overexpression, induced by high extracellular potassium concentration, could completely rescue the correct filament organization while, under the same experimental conditions, in cells expressing the severe p.R239C mutant only a partial rescue effect could be achieved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197187     DOI: 10.1038/sj.ejhg.5201995

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  9 in total

Review 1.  Strategies for treatment in Alexander disease.

Authors:  Albee Messing; Christine M LaPash Daniels; Tracy L Hagemann
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

2.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

3.  Alexander Disease Modeling in Zebrafish: An In Vivo System Suitable to Perform Drug Screening.

Authors:  Simona Candiani; Silvia Carestiato; Andreas F Mack; Daniele Bani; Matteo Bozzo; Valentina Obino; Michela Ori; Francesca Rosamilia; Miriam De Sarlo; Mario Pestarino; Isabella Ceccherini; Tiziana Bachetti
Journal:  Genes (Basel)       Date:  2020-12-11       Impact factor: 4.096

Review 4.  Identification of a novel de novo pathogenic variant in GFAP in an Iranian family with Alexander disease by whole-exome sequencing.

Authors:  Katayoun Heshmatzad; Niloofar Naderi; Tannaz Masoumi; Hamidreza Pouraliakbar; Samira Kalayinia
Journal:  Eur J Med Res       Date:  2022-09-10       Impact factor: 4.981

5.  Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant.

Authors:  Laura Melchionda; Mingyan Fang; Hairong Wang; Valeria Fugnanesi; Michela Morbin; Xuanzhu Liu; Wenyan Li; Isabella Ceccherini; Laura Farina; Mario Savoiardo; Pio D'Adamo; Jianguo Zhang; Alfredo Costa; Sabrina Ravaglia; Daniele Ghezzi; Massimo Zeviani
Journal:  Orphanet J Rare Dis       Date:  2013-05-01       Impact factor: 4.123

6.  Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.

Authors:  So-Hyun Lee; Tai-Seung Nam; Kun-Hee Kim; Jin Hee Kim; Woong Yoon; Suk-Hee Heo; Min Jung Kim; Boo Ahn Shin; Ming-Der Perng; Hyon E Choy; Jihoon Jo; Myeong-Kyu Kim; Seok-Yong Choi
Journal:  BMC Neurol       Date:  2017-09-07       Impact factor: 2.474

7.  Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander's Disease.

Authors:  Tiziana Bachetti; Eleonora Di Zanni; Annalisa Adamo; Francesca Rosamilia; M Margherita Sechi; Paolo Solla; Matteo Bozzo; Isabella Ceccherini; GianPietro Sechi
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

8.  Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes.

Authors:  E Tian; Guoqiang Sun; Guihua Sun; Jianfei Chao; Peng Ye; Charles Warden; Arthur D Riggs; Yanhong Shi
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.995

9.  Does genetic anticipation occur in familial Alexander disease?

Authors:  Camille K Hunt; Ahmad Al Khleifat; Ella Burchill; Joerg Ederle; Ammar Al-Chalabi; Jemeen Sreedharan
Journal:  Neurogenetics       Date:  2021-05-28       Impact factor: 2.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.